Mark Lunt

25.2k citations
382 papers · 20.1k · 4 hit papers · h-index 79

Impact in

  • Rheumatology top 0.05%
    • Rheumatoid Arthritis Research and Therapies
    • Spondyloarthritis Studies and Treatments
    • Systemic Lupus Erythematosus Research
    • Bone health and osteoporosis research

Papers in

Mark Lunt

365 papers receiving 19.1k citations

Mark Lunt's Hit Papers

Anti-TNF therapy is associated with an increased risk of serious infections in patients with rheumatoid arthritis especially in the first 6 months of treatment: updated results from the British Society for Rheumatology Biologics Register with special emphasis on risks in the elderly 2010 · 557 citations
5570+6+13Years since publication200400600

Peers

Mark Lunt
Comparison fields: 5 of 183
  • Rheumatology 8.2k
  • Orthopedics and Sports Medicine 2.3k
  • Immunology 2.1k
  • Complementary and Manual Therapy 152
  • Pathology and Forensic Medicine 948
Replace Bernard G Combe with:
Bernard G Combe France
Jeffrey R. Curtis United States
Karen Costenbader United States
Janet Elizabeth Pope Canada
Kaleb D. Michaud United States
Ted R. Mikuls United States
Paul R. Fortin Canada
Richard J. Cook Canada
William Gregory Dixon United Kingdom
Daniel Prieto‐Alhambra United Kingdom
Mark Lunt relative to Bernard G Combe France Bernard G Combe's profile →
Citations per field
00.5×2×3×4.1×
Bernard G Combe · 1×
Citations per year

Countries citing papers authored by Mark Lunt

Since Specialization
Citations

This map shows the geographic impact of Mark Lunt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Lunt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Lunt more than expected).

Fields of papers citing papers by Mark Lunt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Lunt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Lunt. The network helps show where Mark Lunt may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark Lunt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark Lunt Line = papers co-authored together Mark Lunt links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 382 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Rates of serious infection, including site‐specific and bacterial intracellular infection, in rheumatoid arthritis patients receiving anti–tumor necrosis factor therapy: Results from the British Society for Rheumatology Biologics Register
Hit paper breakdown →
2006608
2
Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register (BSRBR)
Hit paper breakdown →
2009605
3
Anti-TNF therapy is associated with an increased risk of serious infections in patients with rheumatoid arthritis especially in the first 6 months of treatment: updated results from the British Society for Rheumatology Biologics Register with special emphasis on risks in the elderly
Hit paper breakdown →
2010557
4
Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti–tumor necrosis factor α therapy: Results from the British Society for Rheumatology Biologics Register
Hit paper breakdown →
2007475
5 2003357
6 2006342
7 2015327
8 2002299
9 2005278
10 2013272
11 2007251
12 2005247
13 2001237
14 2002226
15 2008209
16 2005201
17 2014195
18 2003194
19 2010187
20 2011184

About Mark Lunt

Mark Lunt is a scholar working on Rheumatology, Orthopedics and Sports Medicine, Immunology, Statistics and Probability and Pharmacology, having authored 382 papers that have together received 20.1k indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (155 papers), Psoriasis: Treatment and Pathogenesis (40 papers), Bone health and osteoporosis research (39 papers), Musculoskeletal pain and rehabilitation (18 papers), Autoimmune and Inflammatory Disorders Research (15 papers), Advanced Causal Inference Techniques (12 papers), Systemic Sclerosis and Related Diseases (10 papers) and Systemic Lupus Erythematosus Research (10 papers). The work is most often cited by research in Rheumatology (8.2k citations), Orthopedics and Sports Medicine (2.3k citations), Immunology (2.1k citations), Complementary and Manual Therapy (152 citations) and Pathology and Forensic Medicine (948 citations). Mark Lunt has collaborated with scholars based in United Kingdom, Germany and United States. Frequent co-authors include Deborah P. M. Symmons, Kimme Leanne Hyrich, Alan J. Silman, Kath D. Watson, William Gregory Dixon, James Benjamin Galloway, Diane K Bunn, Louise Mercer, Andrew Ustianowski and Terence W O’Neill. Their work appears in journals such as Lara D. Veeken, Annals of the Rheumatic Diseases, British Journal of Dermatology, Osteoporosis International and Arthritis Care & Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact